Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers.

Saved in:
Bibliographic Details
Title: Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers.
Authors: Aronson MR; Department of Biomedical Engineering, Penn State University, University Park, PA 16802 USA., Dahl ES; Department of Cellular & Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033 USA., Halle JA; Department of Biomedical Engineering, Penn State University, University Park, PA 16802 USA., Simonson AW; Department of Biomedical Engineering, Penn State University, University Park, PA 16802 USA., Gogal RA; Department of Veterinary and Biomedical Sciences, Penn State University, University Park, PA 16802 USA., Glick AB; Department of Veterinary and Biomedical Sciences, Penn State University, University Park, PA 16802 USA.; Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802 USA., Aird KM; Department of Cellular & Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033 USA., Medina SH; Department of Biomedical Engineering, Penn State University, University Park, PA 16802 USA.; Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802 USA.; Department of Biomedical Engineering, The Pennsylvania State University, Suite 122, CBE Building, University Park, PA 16802-4400 USA.
Source: Cellular and molecular bioengineering [Cell Mol Bioeng] 2020 Jun 24; Vol. 13 (5), pp. 447-461. Date of Electronic Publication: 2020 Jun 24 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101468590 Publication Model: eCollection Cited Medium: Print ISSN: 1865-5025 (Print) Linking ISSN: 18655025 NLM ISO Abbreviation: Cell Mol Bioeng Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1865-5025
DOI:10.1007/s12195-020-00626-z